New figures released this month by the Turkish Statistics Institute show that Turkey’s domestic R&D grew 20.4% in 2011 to TRY 11,154 million ($6,374 million = TRY 1.75 = $1), following a 14.6% increase in 2010. Labor, “other current costs” (non-capital materials and supplies, administrative costs, indirect service), instruments and equipment, and land and buildings […]
Company Announcements In August, Danaher acquired Hangzhou Dingli Environmental, a Chinese distributor of Hach products for online water quality instrumentation. In September, Pall announced that its New England Life Sciences Center of Excellence in Westborough, Massachusetts, will open in spring 2013. The 113,000-square-foot facility will provide a range of process solutions. Existing operations in Northborough, […]
For some of the acquisition reported in IBO over the last year, purchase prices were not available at the time of the announcement. The table below shows the prices for acquired companies that were later disclosed in regulatory filings or company reports. Bio-Rad Laboratories also disclosed in its third-quarter regulatory filing that it paid $5 […]
Despite weak academic and government spending, third-quarter IBO Laboratory Sales Index grew 1.2%, 3.8% excluding currency, to $5,839 million. Operating profit improved 1.4% to $1,165 million. Based on continuing operations, operating margin was unchanged at 18.8% of sales. For the three companies that did not report earnings before this issue’s publication (Agilent Technologies, Spectris and […]
Choppy third-quarter corporate earnings along with a generally cautious outlook led the Dow Jones Industrial Average, S&P 500 and NASDAQ down 2.5%, 2.0% and 4.5% in October, respectively. However, other economic data, including better-than-expected new home sales and jobless claims, indicated improved financial conditions. Third-quarter GDP growth, while still tepid at 2.0%, improved from the […]
According to the results of IBO’s Fall 2012 Business Climate Survey, expectations for near-term instrument and laboratory product sales have hit their lowest point since spring 2009 (see graph, page 6). Twenty-four percent of respondents expect instrument and lab product sales to decline industry wide over the calendar-year fourth quarter 2012 and first quarter 2013. […]
Washington, DC 9/28/12; Washington, DC 10/3/12—Singulex, a provider of immunoassay technology for measuring single-molecule changes in biomarkers, has filed with the US SEC for an IPO. The company intends to raise $86.3 million. In 2011, the company’s revenues grew 405% to $24.8 million, with cardiovascular disease (CVD) monitoring services accounting for 78% of revenues, life […]
Santa Clara, CA 10/8/12—Affymetrix has announced that it expects third-quarter revenues of $80 million, including eBioscience sales of $18 million, based on preliminary financial data. “Based on ongoing concerns about global academic funding as well as a weaker euro, we now believe that total revenue for Affymetrix excluding eBioscience will be flat to slightly down […]
Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index improved 0.7%, 2.0% excluding currency, to $4,061 million. Operating profits for the Index rose 4.0% to $737 million. Based on continuing operations, operating margin slipped 30 basis points to 17.9% of sales. For the fiscal third quarter ending August 31, revenue for Gerresheimer Life Science Research grew […]
US, European and Japanese central banks all implemented new economic stimulus strategies this month. The European Central Bank announced plans to buy unlimited government debt, and the Bank of Japan increased its asset purchase program. On September 13, the US Federal Reserve agreed to purchase $40 billion of mortgage securities each month until the economy […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
